Brendan Harte
Chairman at ICON Clinical Research GmbH
Profile
Brendan Harte currently works at ICON Clinical Research GmbH, as Chairman-Supervisory Board, Science Foundation Ireland, as Director, ICON Clinical Research (U.K.) Ltd., as Director from 2009, ICON Clinical Research Germany GmbH, as Co-Managing Director, and VSK (Kenilworth) Ltd., as Director from 2019.
Brendan Harte active positions
| Companies | Position | Start |
|---|---|---|
ICON Clinical Research (U.K.) Ltd.
 ICON Clinical Research (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research (U.K.) Ltd. engages in research and experimental development on natural sciences and engineering services. The company is headquartered in Eastleigh, the United Kingdom. | Director/Board Member | 2009-12-16 |
ICON Clinical Research GmbH
 ICON Clinical Research GmbH Pharmaceuticals: MajorHealth Technology Part of ICON plc, ICON Clinical Research GmbH is a clinical research organization that provides outsourced clinical development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. The company is based in Langen, Germany. The CEOs of the German company are Alan Sheehan, Christoph Zanke. | Chairman | - |
Science Foundation Ireland
 Science Foundation Ireland Miscellaneous Commercial ServicesCommercial Services Science Foundation Ireland funds oriented basic and applied research in the areas of science, technology, engineering, and mathematics (STEM). It promotes and supports the study of, education in, and engagement with STEM and promotes an awareness and understanding of the value of STEM to society. The company was founded in 1998 and is headquartered in Dublin, Ireland,. | Director/Board Member | - |
VSK (Kenilworth) Ltd.
 VSK (Kenilworth) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ICON plc, VSK (Kenilworth) Ltd. is a holding British company that operates subsidiaries providing clinical research services. The company is based in Eastleigh, UK and was founded in 2010. | Director/Board Member | 2019-08-26 |
Former positions of Brendan Harte
| Companies | Position | End |
|---|---|---|
| ICON Clinical Research Germany GmbH | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Science Foundation Ireland
Science Foundation Ireland Miscellaneous Commercial ServicesCommercial Services Science Foundation Ireland funds oriented basic and applied research in the areas of science, technology, engineering, and mathematics (STEM). It promotes and supports the study of, education in, and engagement with STEM and promotes an awareness and understanding of the value of STEM to society. The company was founded in 1998 and is headquartered in Dublin, Ireland,. | Commercial Services |
ICON Clinical Research (U.K.) Ltd.
ICON Clinical Research (U.K.) Ltd. Miscellaneous Commercial ServicesCommercial Services ICON Clinical Research (U.K.) Ltd. engages in research and experimental development on natural sciences and engineering services. The company is headquartered in Eastleigh, the United Kingdom. | Commercial Services |
ICON Clinical Research GmbH
ICON Clinical Research GmbH Pharmaceuticals: MajorHealth Technology Part of ICON plc, ICON Clinical Research GmbH is a clinical research organization that provides outsourced clinical development and commercialization services to the pharmaceutical, biotechnology, and medical device industries. The company is based in Langen, Germany. The CEOs of the German company are Alan Sheehan, Christoph Zanke. | Health Technology |
| ICON Clinical Research Germany GmbH | Commercial Services |
VSK (Kenilworth) Ltd.
VSK (Kenilworth) Ltd. Miscellaneous Commercial ServicesCommercial Services Part of ICON plc, VSK (Kenilworth) Ltd. is a holding British company that operates subsidiaries providing clinical research services. The company is based in Eastleigh, UK and was founded in 2010. | Commercial Services |
- Stock Market
- Insiders
- Brendan Harte
